Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Oct;94(10):4595-4596.
doi: 10.1002/jmv.27960. Epub 2022 Jul 2.

Response to Finsterer on the letter to the editor "Diagnose SARS-CoV-2 associated Guillain-Barre syndrome upon appropriate criteria and after exclusion of differentials"

Nihal Akçay  1 , Gonca Bektaş  2 , Mehmet Emin Menentoğlu  1 , Esra Şevketoğlu  1
Affiliations
Comment

Response to Finsterer on the letter to the editor "Diagnose SARS-CoV-2 associated Guillain-Barre syndrome upon appropriate criteria and after exclusion of differentials"

Nihal Akçay et al. J Med Virol. 2022 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Comment on

References

    1. Akçay N, Menentoğlu ME, Bektaş G, Şevketoğlu E. Axonal Guillain‐Barre syndrome associated with SARS‐CoV‐2 infection in a child. J Med Virol. 2021;93(9):5599‐5602. 10.1002/jmv.27018 - DOI - PMC - PubMed
    1. Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol. 2011;10(10):931‐941. 10.1016/S1474-4422(11)70178-8 - DOI - PubMed
    1. Sejvar JJ, Kohl KS, Gidudu J, et al. Guillain‐Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011;29(3):599‐612. 10.1016/j.vaccine.2010.06.003 - DOI - PubMed
    1. Koga M, Kusunoki S, Kaida K, et al. Nationwide survey of patients in Japan with Bickerstaff brainstem encephalitis: epidemiological and clinical characteristics. J Neurol Neurosurg Psychiatry. 2012;83(12):1210‐1215. 10.1136/jnnp-2012-303060 - DOI - PubMed
    1. Hassanipour S, Arab‐Zozani M, Amani B, Heidarzad F, Fathalipour M, Martinez‐de‐Hoyo R. The efficacy and safety of Favipiravir in treatment of COVID‐19: a systematic review and meta‐analysis of clinical trials. Sci Rep. 2021;11(1):11022. 10.1038/s41598-021-90551-6 - DOI - PMC - PubMed